Physician profile
Daniel Morris
NPI 1013205970
$10,685.61
in general payments reported to CMS, 2019-2025
30 companies · $1,421 in 2025
The $1,421 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,690 · 2020: $1,627 · 2021: $1,398 · 2022: $1,639 · 2023: $1,362 · 2024: $548 · 2025: $1,421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,696 · Travel and Lodging: $1,635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,696.08 |
| Travel and Lodging | $1,634.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prime Surgical, LLC | $4,663.48 | 2019-2021 | |
| Encore Medical, Lp | $2,106.17 | 2019-2025 | Djo Surgical |
| Stryker Corporation | $1,479.04 | 2022-2023 | Mako |
| Pacira Pharmaceuticals Incorporated | $829.16 | 2023 | Iovera, Exparel, Zilretta |
| Depuy Synthes Sales INC. | $206.35 | 2020-2025 | Monovisc, Attune, Tfn-Advance |
| Horizon Therapeutics Plc | $164.29 | 2019-2023 | Krystexxa |
| Djo, LLC | $147.38 | 2023 | Donjoy |
| Nuvasive, INC. | $146.13 | 2022 | |
| Acumed LLC | $113.27 | 2023-2024 | Acumed |
| Amgen INC. | $93.98 | 2023-2025 | Evenity, Prolia, Krystexxa |
| Bioventus LLC | $79.63 | 2019-2022 | |
| Urgo Medical North America, LLC | $75.45 | 2025 | Urgoclean Ag, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Ethicon US, LLC | $68.92 | 2019-2020 | |
| Boston Scientific Corporation | $58.87 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Kci USA, INC. | $43.47 | 2021-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $39.83 | 2022-2025 | Zynrelef |
| Heraeus Medical, LLC. | $39.58 | 2025 | |
| Solventum Corporation | $36.18 | 2025 | V.A.C. Veraflo, Prevena |
| Smith+Nephew, INC. | $32.82 | 2022 | |
| Radius Health, INC. | $30.06 | 2019 | |
| Endo Pharmaceuticals INC. | $29.67 | 2021-2023 | Xiaflex |
| Biocomposites INC | $29.12 | 2025 | Stimulan |
| Davol INC. | $27.44 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $26.95 | 2022 | |
| Trimed, INC. | $25.60 | 2024 | |
| Kerecis Limited | $24.66 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Conmed Corporation | $21.40 | 2025 | Visiclear, Abc Handpieces |
| Endo USA, INC. | $18.86 | 2025 | Xiaflex |
| Avanos Medical | $16.49 | 2024 | Generator |
| Ermi LLC | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.